Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Starkstein

Showing results (231-240 of 257) with videos related to

Pageof 26
Sort By:
The American Journal of Psychiatry|July 1, 1992
Depression in patients with acute traumatic brain injuryJ P Fedoroff, S E Starkstein, A W Forrester, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 13, 2020
Risk factors and outcomes of anxiety symptom trajectories in type 2 diabetes: the Fremantle Diabetes Study Phase IIS R Whitworth, D G Bruce, S E Starkstein, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 30, 2014
Is the Parkinson Anxiety Scale comparable across raters?Maria João Forjaz, Alba Ayala, Pablo Martinez-Martin, et al.
World Journal of Psychiatry|April 18, 2022
Spectrum of neuropsychiatric symptoms in chronic post-stroke aphasiaLisa Edelkraut, Diana López-Barroso, María José Torres-Prioris, et al.
European Journal of Neurology|April 16, 2013
Designing a new scale to measure anxiety symptoms in Parkinson's disease: item selection based on canonical correlation analysisP Martinez-Martin, J M Rojo-Abuin, K Dujardin, et al.
Annals of Neurology|July 1, 1990
Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's diseaseH S Mayberg, S E Starkstein, B Sadzot, et al.
Diabetes Care|July 25, 2008
Predictors of cognitive decline in older individuals with diabetesDavid G Bruce, Wendy A Davis, Genevieve P Casey, et al.
The American Journal of Psychiatry|March 4, 2000
Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind studyR G Robinson, S K Schultz, C Castillo, et al.
Neurology|August 16, 2013
Modeling depression in Parkinson disease: disease-specific and nonspecific risk factorsAlbert F G Leentjens, Anja J H Moonen, Kathy Dujardin, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 9, 2013
Anxiety has specific syndromal profiles in Parkinson disease: a data-driven approachSergio E Starkstein, Milan Dragovic, Kathy Dujardin, et al.
Pageof 26

Showing results (231-240 of 257) with videos related to

Sort By:
Pageof 26
The American Journal of Psychiatry|July 1, 1992
Depression in patients with acute traumatic brain injuryJ P Fedoroff, S E Starkstein, A W Forrester, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 13, 2020
Risk factors and outcomes of anxiety symptom trajectories in type 2 diabetes: the Fremantle Diabetes Study Phase IIS R Whitworth, D G Bruce, S E Starkstein, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 30, 2014
Is the Parkinson Anxiety Scale comparable across raters?Maria João Forjaz, Alba Ayala, Pablo Martinez-Martin, et al.
World Journal of Psychiatry|April 18, 2022
Spectrum of neuropsychiatric symptoms in chronic post-stroke aphasiaLisa Edelkraut, Diana López-Barroso, María José Torres-Prioris, et al.
European Journal of Neurology|April 16, 2013
Designing a new scale to measure anxiety symptoms in Parkinson's disease: item selection based on canonical correlation analysisP Martinez-Martin, J M Rojo-Abuin, K Dujardin, et al.
Annals of Neurology|July 1, 1990
Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's diseaseH S Mayberg, S E Starkstein, B Sadzot, et al.
Diabetes Care|July 25, 2008
Predictors of cognitive decline in older individuals with diabetesDavid G Bruce, Wendy A Davis, Genevieve P Casey, et al.
The American Journal of Psychiatry|March 4, 2000
Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind studyR G Robinson, S K Schultz, C Castillo, et al.
Neurology|August 16, 2013
Modeling depression in Parkinson disease: disease-specific and nonspecific risk factorsAlbert F G Leentjens, Anja J H Moonen, Kathy Dujardin, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 9, 2013
Anxiety has specific syndromal profiles in Parkinson disease: a data-driven approachSergio E Starkstein, Milan Dragovic, Kathy Dujardin, et al.
Pageof 26